Two Weeks of Metformin Treatment Enhances Mitochondrial Respiration in Skeletal Muscle of AMPK Kinase Dead but Not Wild Type Mice
Open accessThe DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Abstract
Metformin is used as an anti-diabetic drug. Metformin ameliorates insulin resistance by improving insulin sensitivity in liver and skeletal muscle. Reduced mitochondrial content has been reported in type 2 diabetic muscles and it may contribute to decreased insulin sensitivity characteristic for diabetic muscles. The molecular mechanism behind the effect of metformin is not fully clarified but inhibition of complex I in the mitochondria and also activation of the 5'AMP activated protein kinase (AMPK) has been reported in muscle. Furthermore, both AMPK activation and metformin treatment have been associated with stimulation of mitochondrial function and biogenesis. However, a causal relationship in skeletal muscle has not been investigated. We hypothesized that potential effects of in vivo metformin treatment on mitochondrial function and protein expressions in skeletal muscle are dependent upon AMPK signaling. We investigated this by two weeks of oral metformin treatment of muscle specific kinase dead α(2) (KD) AMPK mice and wild type (WT) littermates. We measured mitochondrial respiration and protein activity and expressions of key enzymes involved in mitochondrial carbohydrate and fat metabolism and oxidative phosphorylation. Mitochondrial respiration, HAD and CS activity, PDH and complex I-V and cytochrome c protein expression were all reduced in AMPK KD compared to WT tibialis anterior muscles. Surprisingly, metformin treatment only enhanced respiration in AMPK KD mice and thereby rescued the respiration defect compared to the WT mice. Metformin did not influence protein activities or expressions in either WT or AMPK KD mice.We conclude that two weeks of in vivo metformin treatment enhances mitochondrial respiration in the mitochondrial deficient AMPK KD but not WT mice. The improvement seems to be unrelated to AMPK, and does not involve changes in key mitochondrial proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“in mice with AMPK-kinase-dead mutation, even short-term metformin treatment enhances mitochondrial function and biogenesis in skeletal muscle”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as Kristensen et al. 2013
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α
Jäger, S., Handschin, C., St.-Pierre, J., & Spiegelman, B. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705070104 · Cited by 2,491
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
Mitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Clinical pharmacokinetics of metformin
Graham, G. G., Punt, J., Arora, M., Day, R. O., Doogue, M. P., Duong, J. K., Furlong, T. J., Greenfield, J. R., Greenup, L. C., Kirkpatrick, C. M., et al. (2011) · Clinical Pharmacokinetics · doi:10.2165/11534750-000000000-00000 · Cited by 1,318
The AMP‐Activated Protein Kinase: Fuel Gauge of the Mammalian Cell?
Hardie, D. G., & Carling, D. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00259.x · Cited by 1,317
AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling
Towler, M. C., & Hardie, D. G. (2007) · Circulation Research · doi:10.1161/01.res.0000256090.42690.05 · Cited by 1,253
Foretz, M., Hébrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F., & Viollet, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40671 · Cited by 1,181
Zong, H., Ren, J. M., Young, L. H., Pypaert, M., Mu, J., Birnbaum, M. J., & Shulman, G. I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252625599 · Cited by 1,036 · cited 1×
“Use of pharmacological AMPK activators [33,40,67– 70], genetic models [32,34,55,56,58,71–73] and combination of these [31,33,74] have substantiated AMPK as an important mitochondriogenic part.”
BackgroundFryer, L. G. D., Parbu-Patel, A., & Carling, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202489200 · Cited by 1,029
Mu, J., Brozinick, J. T., Valladares, O., Bucan, M., & Birnbaum, M. J. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00251-9 · Cited by 924
Musi, N., Hirshman, M. F., Nygren, J., Svanfeldt, M., Bavenholm, P., Rooyackers, O., Zhou, G., Williamson, J. M., Ljunqvist, O., Efendic, S., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2074 · Cited by 806 · cited 1×
“In addition, metformin-induced activation of the 5 9 -AMP activated protein kinase (AMPK) has been shown in rodent muscles [18– 20], and in human skeletal muscles from patients with type 2 diabetes [21,22].”
BackgroundActivation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle
Winder, W. W., Holmes, B. F., Rubink, D. S., Jensen, E. B., Chen, M., & Holloszy, J. O. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.6.2219 · Cited by 709
Hawley, S. A., Gadalla, A. E., Olsen, G. S., & Hardie, D. G. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2420 · Cited by 696
Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis
Bergeron, R., Ren, J. M., Cadman, K. S., Moore, I. K., Perret, P., Pypaert, M., Young, L. H., Semenkovich, C. F., & Shulman, G. I. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1340 · Cited by 561
High-fat diets cause insulin resistance despite an increase in muscle mitochondria
Hancock, C. R., Han, D.-H., Chen, M., Terada, S., Yasuda, T., Wright, D. C., & Holloszy, J. O. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802057105 · Cited by 538
Turner, N., Li, J.-Y., Gosby, A., To, S. W. C., Cheng, Z., Miyoshi, H., Taketo, M. M., Cooney, G. J., Kraegen, E. W., James, D. E., et al. (2008) · Diabetes · doi:10.2337/db07-1552 · Cited by 535
Thiazolidinediones, Like Metformin, Inhibit Respiratory Complex I
Brunmair, B., Staniek, K., Gras, F., Scharf, N., Althaym, A., Clara, R., Roden, M., Gnaiger, E., Nohl, H., Waldhäusl, W., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1052 · Cited by 521 · cited 1×
“Instead activation has been suggested to be linked to the inhibition of mitochondrial complex I, that may lead to a disturbance in cell energy balance and thus AMPK activation [13,27,28], although other studies suggest that the metformin-induced activation is not dependent of such changes in the energy status of the c…”
BackgroundPatients with type 2 diabetes have normal mitochondrial function in skeletal muscle
Boushel, R., Gnaiger, E., Schjerling, P., Skovbro, M., Kraunsøe, R., & Dela, F. (2007) · Diabetologia · doi:10.1007/s00125-007-0594-3 · Cited by 519 · cited 1×
“However, several other studies have not confirmed these findings [6–10].”
ResultSelf-citationKukidome, D., Nishikawa, T., Sonoda, K., Imoto, K., Fujisawa, K., Yano, M., Motoshima, H., Taguchi, T., Matsumura, T., & Araki, E. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0943 · Cited by 504
Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation
Holness, M. J., & Sugden, M. C. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311143 · Cited by 479
O'Neill, H. M., Maarbjerg, S. J., Crane, J. D., Jeppesen, J., Jørgensen, S. B., Schertzer, J. D., Shyroka, O., Kiens, B., van Denderen, B. J., Tarnopolsky, M. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105062108 · Cited by 406
Musi, N., Fujii, N., Hirshman, M. F., Ekberg, I., Fröberg, S., Ljungqvist, O., Thorell, A., & Goodyear, L. J. (2001) · Diabetes · doi:10.2337/diabetes.50.5.921 · Cited by 371
Metformin: A review of its metabolic effects
Cusi, K. J., & DeFronzo, R. A. (1998) · Diabetes reviews · Cited by 310
Skeletal Muscle Adaptation to Exercise Training
Röckl, K. S. C., Hirshman, M. F., Brandauer, J., Fujii, N., Witters, L. A., & Goodyear, L. J. (2007) · Diabetes · doi:10.2337/db07-0255 · Cited by 305 · cited 1×
“Hence, the decreased basal activities of CS and HAD, as key enzymes in the TCA cycle and boxidation, in the present study is a common observation reported in the AMPK KD strain [73,75] and in comparable AMPK genetic model [31,34,55].”
ResultEffect of Acute Exercise on AMPK Signaling in Skeletal Muscle of Subjects with Type 2 Diabetes
Sriwijitkamol, A., Coletta, D. K., Wajcberg, E., Balbontin, G. B., Reyna, S. M., Barrientes, J., Eagan, P. A., Jenkinson, C. P., Cersosimo, E., DeFronzo, R. A., et al. (2007) · Diabetes · doi:10.2337/db06-1119 · Cited by 304
Stephenne, X., Foretz, M., Taleux, N., van der Zon, G. C., Sokal, E., Hue, L., Viollet, B., & Guigas, B. (2011) · Diabetologia · doi:10.1007/s00125-011-2311-5 · Cited by 287 · cited 1×
“Additionally, such a connection was recently demonstrated in AMPK a1a2 double KO hepatocytes showing greater ATP decrease than wild type cells upon metformin incubation [52,59].”
BackgroundBatandier, C., Guigas, B., Detaille, D., El-Mir, M., Fontaine, E., Rigoulet, M., & Leverve, X. M. (2006) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-006-9003-8 · Cited by 279
Effects of α‐AMPK knockout on exercise‐induced gene activation in mouse skeletal muscle
Jørgensen, S. B., Wojtaszewski, J. F. P., Viollet, B., Andreelli, F., Birk, J. B., Hellsten, Y., Schjerling, P., Vaulont, S., Neufer, P. D., Richter, E. A., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3144fje · Cited by 274 · cited 2×
“Use of pharmacological AMPK activators [33,40,67– 70], genetic models [32,34,55,56,58,71–73] and combination of these [31,33,74] have substantiated AMPK as an important mitochondriogenic part.”
BackgroundSelf-citationWoods, A., Salt, I., Scott, J., Hardie, D. G., & Carling, D. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01209-4 · Cited by 260 · cited 1×
“raised in sheep as previously described [43] was kindly donated by Hardie DG, University of Dundee, Scotland, UK.”
MethodRegulation by exercise of skeletal muscle content of mitochondria and GLUT4.
Holloszy, J. O. (2008) · PubMed · Cited by 257
Jensen, T. E., Rose, A. J., Jørgensen, S. B., Brandt, N., Schjerling, P., Wojtaszewski, J. F. P., & Richter, E. A. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00456.2006 · Cited by 217 · cited 1×
“in line with previous studies, using the AMPK KD mice, reporting a1 and a2 activities to be reduced with ,90% [76–78] and ,50% [76,77], respectively, although a1 associated activity in one study was only moderately reduced (,10%) [78].”
ResultSelf-citationSuwa, M., Egashira, T., Nakano, H., Sasaki, H., & Kumagai, S. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00255.2006 · Cited by 210
Hou, X., Song, J., Li, X.-N., Zhang, L., Wang, X., Chen, L., & Shen, Y. H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.04.017 · Cited by 202
Garcia-Roves, P. M., Osler, M. E., Holmström, M. H., & Zierath, J. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805078200 · Cited by 190
Jørgensen, S. B., Treebak, J. T., Viollet, B., Schjerling, P., Vaulont, S., Wojtaszewski, J. F. P., & Richter, E. A. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00243.2006 · Cited by 177
Self-citationSkeletal muscle “mitochondrial deficiency” does not mediate insulin resistance
Holloszy, J. O. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26717c · Cited by 175
Wojtaszewski, J. F. P., Birk, J. B., Frøsig, C., Holten, M., Pilegaard, H., & Dela, F. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.082669 · Cited by 170
Self-citationAMPK‐independent pathways regulate skeletal muscle fatty acid oxidation
Dzamko, N., Schertzer, J. D., Ryall, J. G., Steel, R., Macaulay, S. L., Wee, S., Chen, Z., Michell, B. J., Oakhill, J. S., Watt, M. J., et al. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.159814 · Cited by 147 · cited 1×
“Our observations are in line with previous studies, using the AMPK KD mice, reporting a 1 and a 2 activities to be reduced with , 90% [76–78] and , 50% [76,77], respectively, although a 1 associated activity in one study was only moderately reduced ( , 10”
ResultThomson, D. M., Porter, B. B., Tall, J. H., Kim, H.-J., Barrow, J. R., & Winder, W. W. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00366.2006 · Cited by 146
Lee-Young, R. S., Griffee, S. R., Lynes, S. E., Bracy, D. P., Ayala, J. E., McGuinness, O. P., & Wasserman, D. H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.021048 · Cited by 145
Aguer, C., Mercier, J. G., Man, C. Y. W., Metz, L., Bordenave, S., Lambert, K., Jean, E., Lantier, L., Bounoua, L., Brun, J. ‐., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1708-x · Cited by 118
Neither LKB1 Nor AMPK Are the Direct Targets of Metformin
Hardie, D. G. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.07.032 · Cited by 113
Effect of metformin on glucose metabolism in mouse soleus muscle.
Bailey, C. J., & Puah, J. A. (1986) · PubMed · Cited by 112
Zhang, L., He, H., & Balschi, J. A. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00002.2007 · Cited by 112
Mitochondrial oxidative function and type 2 diabetes
Rabøl, R., Boushel, R., & Dela, F. (2006) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h06-071 · Cited by 112
Self-citationJoseph, A.-M., Pilegaard, H., Litvintsev, A., Leick, L., & Hood, D. A. (2006) · Essays in Biochemistry · doi:10.1042/bse0420013 · Cited by 111
Putman, C. T., Kiricsi, M., Pearcey, J., MacLean, I. M., Bamford, J. A., Murdoch, G. K., Dixon, W. T., & Pette, D. (2003) · The Journal of Physiology · doi:10.1111/j.1469-7793.2003.00169.x · Cited by 110 · cited 1×
“Use of pharmacological AMPK activators [33,40,67– 70], genetic models [32,34,55,56,58,71–73] and combination of these [31,33,74] have substantiated AMPK as an important mitochondriogenic part.”
BackgroundPutman, C. T., Kiricsi, M., Pearcey, J., MacLean, I. M., Bamford, J. A., Murdoch, G. K., Dixon, W. T., & Pette, D. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.040691 · Cited by 110
Pénicaud, L., Hitier, Y., Ferré, P., & Girard, J. (1989) · Biochemical Journal · doi:10.1042/bj2620881 · Cited by 105
Leick, L., Fentz, J., Biensø, R. S., Knudsen, J. G., Jeppesen, J., Kiens, B., Wojtaszewski, J. F. P., & Pilegaard, H. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00648.2009 · Cited by 101
Self-citationKane, D. A., Anderson, E. J., Price, J. W., Woodlief, T. L., Lin, C.-T., Bikman, B. T., Cortright, R. N., & Neufer, P. D. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.06.022 · Cited by 99
Maarbjerg, S. J., Jørgensen, S. B., Rose, A. J., Jeppesen, J., Jensen, T. E., Treebak, J. T., Birk, J. B., Schjerling, P., Wojtaszewski, J. F. P., & Richter, E. A. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90653.2008 · Cited by 92
Self-citationMetformin promotes isolated rat liver mitochondria impairment
Carvalho, C., Correia, S. C., Santos, M. S., Seiça, R. M. F., Oliveira, C. R., & Moreira, P. I. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9614-3 · Cited by 88 · cited 1×
“If metformin, as shown in cell studies [11–14, 52 ], also inhibits complex I in these in vivo settings, there could be a potential redirection of substrate flux Like in the AMPK defective mice, reduced mitochondrial content have been reported in skeletal muscles from patients with type 2 diabetes…”
BackgroundMetformin-Treated Patients With Type 2 Diabetes Have Normal Mitochondrial Complex I Respiration
Larsen, S., Rabøl, R., Hansen, C. N., Madsbad, S., Helge, J. W., & Dela, F. (2012) · Diabetologia · doi:10.1007/s00125-011-2340-0 · Cited by 81
Self-citationHøjlund, K., Mustard, K. J., Stæhr, P., Hardie, D. G., Beck-Nielsen, H., Richter, E. A., & Wojtaszewski, J. F. P. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00326.2003 · Cited by 80
Self-citationAl-Khalili, L., Forsgren, M., Kannisto, K., Zierath, J. R., Lönnqvist, F., & Krook, A. (2005) · Diabetologia · doi:10.1007/s00125-005-1741-3 · Cited by 78 · cited 1×
“In muscles, stimulation of PGC-1 a , a key regulator of mitochondrial biogenesis [38], has been reported both in vitro and in vivo after long term metformin treatment [20,39,40] together with increased activities and protein expressions of mitochondrial marker enzymes [20,40].”
BackgroundPDH-E1α Dephosphorylation and Activation in Human Skeletal Muscle During Exercise
Pilegaard, H., Birk, J. B., Sacchetti, M., Mourtzakis, M., Hardie, D. G., Stewart, G., Neufer, P. D., Saltin, B., van Hall, G., & Wojtaszewski, J. F. P. (2006) · Diabetes · doi:10.2337/db06-0152 · Cited by 74
Self-citationIncreased mitochondrial substrate sensitivity in skeletal muscle of patients with type 2 diabetes.
Larsen, S., Stride, N., Hey-Mogensen, M., Hansen, C. N., Andersen, J. L., Madsbad, S., Worm, D., Helge, J. W., & Dela, F. (2011) · Diabetologia · doi:10.1007/s00125-011-2098-4 · Cited by 73 · cited 1×
“This perspective is supported by newly published observations in muscles from patients with type 2 diabetes [7,16].”
ResultSelf-citationLuna, V., Casauban, L., Sajan, M. P., Gomez-Daspet, J., Powe, J. L., Miura, A., Rivas, J., Standaert, M. L., & Farese, R. V. (2006) · Diabetologia · doi:10.1007/s00125-005-0112-4 · Cited by 55
Skeletal muscle dysfunction in muscle-specific LKB1 knockout mice.
Thomson, D. M., Hancock, C. R., Evanson, B. G., Kenney, S. G., Malan, B. B., Mongillo, A. D., Brown, J. D., Hepworth, S., Fillmore, N., Parcell, A. C., et al. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01293.2009 · Cited by 45
Irving, B. A., Short, K. R., Nair, K. S., & Stump, C. S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2863 · Cited by 42
Williams, D. B., Sutherland, L., Bomhof, M. R., Basaraba, S. A. U., Thrush, A. B., Dyck, D. J., Field, C. J., & Wright, D. C. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90913.2008 · Cited by 39 · cited 1×
“Use of pharmacological AMPK activators [33,40,67– 70], genetic models [32,34,55,56,58,71–73] and combination of these [31,33,74] have substantiated AMPK as an important mitochondriogenic part.”
BackgroundLack of AMPKα2 enhances pyruvate dehydrogenase activity during exercise
Klein, D. K., Pilegaard, H., Treebak, J. T., Jensen, T. E., Viollet, B., Schjerling, P., & Wojtaszewski, J. F. P. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00382.2007 · Cited by 38 · cited 4×
“Use of pharmacological AMPK activators [33,40,67– 70], genetic models [32,34,55,56,58,71–73] and combination of these [31,33,74] have substantiated AMPK as an important mitochondriogenic part.”
BackgroundResultInfluentialSelf-citationGenetic and metabolic effects on skeletal muscle AMPK in young and older twins
Mortensen, B., Poulsen, P., Wegner, L., Stender-Petersen, K. L., Ribel-Madsen, R., Friedrichsen, M., Birk, J. B., Vaag, A., & Wojtaszewski, J. F. P. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00058.2009 · Cited by 36
Self-citationStümvoll, M., Häring, H., & Matthaei, S. (2007) · Endocrine Research · doi:10.1080/07435800701743828 · Cited by 36
Borst, S. E., & Snellen, H. G. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01225-5 · Cited by 35
Mitochondria as Potential Targets in Antidiabetic Therapy
Moreira, P. I., & Oliveira, C. R. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_14 · Cited by 32 · cited 1×
“reduced mitochondrial content as well as protein expressions and activities and this may contribute to skeletal muscle insulin resistance [3–5].”
BackgroundBorst, S. E., Snellen, H. G., & Lai, H. L. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00612-3 · Cited by 29
Halimi, S. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70309-9 · Cited by 27 · cited 1×
“type 2 diabetes and have been utilized in the clinic for more than five decades to improve insulin sensitivity [1,2].”
BackgroundBikman, B. T., Zheng, D., Kane, D. A., Anderson, E. J., Woodlief, T., Price, J. W., Dohm, G. L., Neufer, P. D., & Cortright, R. N. (2010) · Journal of Obesity · doi:10.1155/2010/970865 · Cited by 24
Bamford, J. A., Lopaschuk, G. D., MacLean, I. M., Reinhart, M. L., Dixon, W. T., & Putman, C. T. (2003) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y03-110 · Cited by 24
Bland, M. L., & Birnbaum, M. J. (2011) · Science · doi:10.1126/science.1208444 · Cited by 23
Brown, J. D., Hancock, C. R., Mongillo, A. D., Barton, J. B., DiGiovanni, R. A., Parcell, A. C., Winder, W. W., & Thomson, D. M. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02226.x · Cited by 13
Skeletal muscle mitochondrial respiration in AMPK α2 kinase‐dead mice
Larsen, S., Kristensen, J. M., Stride, N. O., Wojtaszewski, J. F. P., Helge, J. W., & Dela, F. (2011) · Acta Physiologica · doi:10.1111/j.1748-1716.2011.02399.x · Cited by 7
Self-citation
Research works printed but not linked: 1
- SB Jorgensen, 2006, Role of {alpha}2-AMPK in basal, training- and AICAR-induced GLUT4, hexokinase II and mitochondrial protein expression in mouse muscle, Am J Physiol Endocrinol Metab
Cited by
Benefits of Metformin in Attenuating the Hallmarks of Aging
Kulkarni, A. S., Gubbi, S., & Barzilai, N. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.001 · Cited by 766
“But, in mice with AMPK-kinase-dead mutation, even short-term metformin treatment enhances mitochondrial function and biogenesis in skeletal muscle (Kristensen et al. 2013).”
BackgroundAMPK controls exercise endurance, mitochondrial oxidative capacity, and skeletal muscle integrity.
Lantier, L., Fentz, J., Mounier, R., Leclerc, J., Treebak, J. T., Pehmøller, C., Sanz, N., Sakakibara, I., Saint‐Amand, E., Rimbaud, S., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-250449 · Cited by 228
“These findings are supported by previous studies in AMPK 2-KD mice, in which mitochondrial ATP production and state 3 respiration were decreased in permeabilized fibers, indicative of mitochondrial dysfunction (46, 47).”
ResultSelf-citationMora, J. C., & Valencia, W. M. (2018) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2017.08.007 · Cited by 196
Ashabi, G., Khodagholi, F., Khalaj, L., Goudarzvand, M., & Nasiri, M. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-013-9475-2 · Cited by 131
“scientific papers reporting that metformin could decrease apoptotic cell death in vitro and in vivo models of hypoxic and ischemic condition in skeletal muscle, liver and heart (Vytla and Ochs 2013; Viollet and Foretz 2013; Kristensen et al. 2013).”
Wessels, B., Ciapaite, J., van den Broek, N. M. A., Nicolay, K., & Prompers, J. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100525 · Cited by 110
“A dosage of 30 mg/kg/day is typically prescribed for diabetes patients, while, because of the lower bioavailability of metformin in rats compared with humans, , 100–300 mg/kg/day metformin is needed to attain similar effects on glucose homeostasis in rats [3,16–21].”
Influential
Metadata
- Authors
- Kristensen, J. M., Larsen, S., Helge, J. W., Dela, F., & Wojtaszewski, J. F. P.
- Affiliations
- University of Copenhagen (DK)
- Corresponding author
- Kristensen, Jonas M.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-01-14
- Volume
- 8
- Issue
- 1
- Pages
- e53533
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3544921
- OpenAlex
- W2049546134
- Cited by
- 48
- References
- 77
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2022: 2 · 2021: 4 · 2020: 3 · 2019: 2 · 2018: 4 · 2017: 10 · 2016: 7 · 2015: 5 · 2014: 5 · 2013: 2
- FWCI
- 2.84
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- Sundhed og Sygdom, Det Frie Forskningsråd
- Ministério da Ciência, Tecnologia e Inovação
- Lundbeckfonden
- Novo Nordisk
- Nordea-fonden
- Novo Nordisk Fonden
- H. Lundbeck A/S
- Diabetesforeningen
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- metformin, AMPK, skeletal muscle, mitochondrial respiration, type 2 diabetes, insulin resistance, mitochondrial biogenesis, oxidative phosphorylation, mitochondrial complex I, pyruvate dehydrogenase, citrate synthase, malate dehydrogenase, cytochrome c, tibialis anterior
- MeSH terms
- Animals, Citrate (si)-Synthase, Electron Transport, Female, Metformin, Mice, Inbred C57BL, Mitochondria, Phosphorylation, Phosphoserine, Pyruvate Dehydrogenase Complex, Substrate Specificity, 3-Hydroxyacyl CoA Dehydrogenases, Blotting, Western, Muscle, Skeletal, Cell Respiration, Mitochondrial Proteins, Cytochromes c, Mice, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.